MX2018009539A - Uso de comunidades microbianas para la salud humana y animal. - Google Patents
Uso de comunidades microbianas para la salud humana y animal.Info
- Publication number
- MX2018009539A MX2018009539A MX2018009539A MX2018009539A MX2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A MX 2018009539 A MX2018009539 A MX 2018009539A
- Authority
- MX
- Mexico
- Prior art keywords
- human
- animal health
- microbial communities
- mixture
- prevent
- Prior art date
Links
- 230000000813 microbial effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/26—Means for regulation, monitoring, measurement or control, e.g. flow regulation of pH
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M41/00—Means for regulation, monitoring, measurement or control, e.g. flow regulation
- C12M41/30—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration
- C12M41/34—Means for regulation, monitoring, measurement or control, e.g. flow regulation of concentration of gas
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/513—Adolescentes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Sustainable Development (AREA)
- Analytical Chemistry (AREA)
- Physiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
La presente invención se refiere a una mezcla de bacterias que pertenecen a al menos 6 o 7 especies bacterianas diferentes y específicas preferiblemente, para usarlas para prevenir o tratar trastornos gastrointestinales. Preferiblemente, dicha mezcla de bacterias se cultivan juntas en un fermentador, antes de administrar la mezcla a un sujeto, con el fin de prevenir o tratar el trastorno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16154288 | 2016-02-04 | ||
PCT/EP2017/052422 WO2017134240A1 (en) | 2016-02-04 | 2017-02-03 | Use of microbial communities for human and animal health |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2018009539A true MX2018009539A (es) | 2019-02-11 |
Family
ID=55310719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018009539A MX2018009539A (es) | 2016-02-04 | 2017-02-03 | Uso de comunidades microbianas para la salud humana y animal. |
Country Status (24)
Country | Link |
---|---|
US (7) | US11096971B2 (es) |
EP (3) | EP4257194A3 (es) |
JP (3) | JP7016112B2 (es) |
KR (1) | KR20180127972A (es) |
CN (2) | CN108712906B (es) |
AU (2) | AU2017216285B2 (es) |
BR (1) | BR112018015097A2 (es) |
CA (1) | CA3011083A1 (es) |
CY (1) | CY1123954T1 (es) |
DK (2) | DK3639834T3 (es) |
ES (2) | ES2824536T3 (es) |
FI (1) | FI3639834T3 (es) |
HK (1) | HK1257070A1 (es) |
HR (1) | HRP20231182T1 (es) |
HU (2) | HUE051114T2 (es) |
IL (3) | IL293486B2 (es) |
LT (2) | LT3639834T (es) |
MX (1) | MX2018009539A (es) |
PL (2) | PL3639834T3 (es) |
PT (1) | PT3639834T (es) |
RS (2) | RS64782B1 (es) |
RU (2) | RU2758387C2 (es) |
SI (2) | SI3639834T1 (es) |
WO (1) | WO2017134240A1 (es) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113730442A (zh) | 2014-10-31 | 2021-12-03 | 潘德勒姆治疗公司 | 与病症的微生物治疗和诊断有关的方法和组合物 |
ES2824536T3 (es) | 2016-02-04 | 2021-05-12 | Univ Gent | Uso de comunidades microbianas para la salud humana y animal |
EP3423093A4 (en) | 2016-03-04 | 2019-11-13 | The Regents of The University of California | MICROBIAL CONSORTIUM AND USES THEREOF |
WO2018145082A1 (en) * | 2017-02-06 | 2018-08-09 | New York University | Methods and compositions for treating and diagnosing pancreatic cancers |
CN107384828B (zh) * | 2017-08-22 | 2020-06-16 | 中国农业科学院农产品加工研究所 | 阿克曼氏粘细菌培养基及其制备方法 |
CA3073838A1 (en) | 2017-08-30 | 2019-03-07 | Pendulum Therapeutics, Inc. | Methods and compositions for treatment of microbiome-associated disorders |
KR102250597B1 (ko) | 2017-11-20 | 2021-05-11 | 경희대학교 산학협력단 | 신규 유산균 및 이의 용도 |
WO2019098810A2 (ko) * | 2017-11-20 | 2019-05-23 | 경희대학교 산학협력단 | 신규 유산균 및 이의 용도 |
CN113038957A (zh) | 2018-04-10 | 2021-06-25 | 谢尔塔治疗公司 | 微生物群 |
AU2019253616A1 (en) * | 2018-04-13 | 2020-11-05 | Med-Life Discoveries Lp | Long chain dicarboxylic fatty acid (LCDFA) producing microbes and uses thereof |
EP3788134A1 (en) * | 2018-05-04 | 2021-03-10 | 4D Pharma Research Limited | Simulated intestinal environment |
CA3106315A1 (en) * | 2018-07-19 | 2020-01-23 | Pendulum Therapeutics, Inc. | Methods and compositions for microbial engraftment |
US11859214B1 (en) | 2018-08-17 | 2024-01-02 | The Government Of The United States, As Represented By The Secretary Of The Army | Automated system for simulating the human lower gastrointestinal tract |
EP3870691A4 (en) * | 2018-09-13 | 2022-09-07 | Xbiome Inc. | METHODS AND COMPOSITIONS FOR TREATING GASTROINTESTINAL AND INFLAMMATORY DISORDERS |
US20210355431A1 (en) * | 2018-10-15 | 2021-11-18 | Pharmabiome Ag | Method of manufacturing a consortium of bacterial strains |
EP3911161A4 (en) * | 2019-01-16 | 2022-09-14 | Board of Regents, The University of Texas System | METHODS AND COMPOSITIONS FOR THE TREATMENT OF COLITIS-ASSOCIATED IMMUNE CHECKPOINT INHIBITOR |
CN110607262B (zh) * | 2019-09-25 | 2022-03-25 | 君维安(武汉)生命科技有限公司 | 一种干预炎性肠炎的益生菌组合物及其筛选方法和应用 |
CN110448577B (zh) * | 2019-09-26 | 2023-06-23 | 青岛农业大学 | 一种溃疡性结肠炎修复益生菌微胶囊制剂 |
CA3153884A1 (en) | 2019-10-07 | 2021-04-15 | Nikole KIMES | Therapeutic pharmaceutical compositions |
WO2021072322A1 (en) * | 2019-10-09 | 2021-04-15 | Mayo Foundation For Medical Education And Research | Treatment for gastrointestinal disorders |
GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
CN110916192B (zh) * | 2019-11-25 | 2021-04-13 | 垒途智能教科技术研究院江苏有限公司 | 一种具有防治儿童青少年自闭症的益生菌矿物粉及其应用 |
JP2023507204A (ja) | 2019-12-23 | 2023-02-21 | エボニック オペレーションズ ゲーエムベーハー | グルテン分解のためのプロバイオティクス菌株を含む調製物 |
CN114657083A (zh) * | 2019-12-24 | 2022-06-24 | 顾青 | 一种乳酸菌发酵乳 |
CN111117925B (zh) * | 2020-01-13 | 2021-05-25 | 浙江大学 | Anaerostipes sp B2131菌及其在炎症性肠病中的应用 |
CN111413503A (zh) * | 2020-03-28 | 2020-07-14 | 浙江大学 | 骨桥蛋白作为靶分子在调节高脂饮食引起的肥胖中的应用 |
EP4133944A1 (en) * | 2020-04-08 | 2023-02-15 | Megmilk Snow Brand Co. Ltd. | Composition for improving intestinal bacterial flora |
KR20220164594A (ko) * | 2020-04-08 | 2022-12-13 | 소마젠 인크 | 미생물총 내 항생제 유발 불균형에 대한 조성물 및 방법 |
KR102169794B1 (ko) * | 2020-06-24 | 2020-10-27 | 주식회사 엔테로바이옴 | 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도 |
CN111938158B (zh) * | 2020-08-18 | 2023-07-07 | 广东弘元普康医疗科技有限公司 | 一种防止肠道Akkermansia muciniphila菌丰度降低的组合物 |
GB202015687D0 (en) * | 2020-10-02 | 2020-11-18 | Microbiotica Ltd | Therapeutic composition |
CN113215020B (zh) * | 2021-02-22 | 2022-06-17 | 中国科学院微生物研究所 | 罗氏菌mgb-2及其应用 |
CN113214976B (zh) * | 2021-03-29 | 2023-04-14 | 中南大学 | 一种高效筛选嗜酸微生物的装置及其筛选方法 |
BE1029496B1 (fr) * | 2021-08-19 | 2023-01-16 | The Akkermansia Company | Composition comprenant de l'Akkermansia muciniphila pasteurisée pour le traitement ou la prévention des troubles de la contractilité intestinale, en particulier des troubles de l'amplitude de la contractilité duodénale |
WO2023126384A1 (en) | 2021-12-27 | 2023-07-06 | Mrm Health N.V. | Microbial communities |
CN114292781B (zh) * | 2021-12-28 | 2023-08-01 | 中山大学 | 一种长双歧杆菌sysu-02及其应用 |
CN114304380A (zh) * | 2022-01-13 | 2022-04-12 | 合肥河川生物医药科技有限公司 | 普拉梭菌在猪鸡上的应用 |
NL2032642B1 (en) * | 2022-07-29 | 2024-02-06 | Academisch Ziekenhuis Leiden | Improvement of muscle mass and strength |
WO2024049207A1 (ko) * | 2022-08-31 | 2024-03-07 | 주식회사 바이오뱅크힐링 | 신규 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도 |
CN115737687A (zh) * | 2022-10-16 | 2023-03-07 | 新疆医科大学第一附属医院 | 普拉梭菌在制备预防或/和治疗冠心病药物或/和保健品中的应用 |
CN116836880B (zh) * | 2023-07-24 | 2023-11-28 | 中山大学 | 一种普氏梭杆菌及其应用 |
CN116925975B (zh) * | 2023-08-18 | 2024-01-23 | 善恩康生物科技(苏州)有限公司 | 一种Akkermansia muciniphila及其产品和应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0307026D0 (en) * | 2003-03-27 | 2003-04-30 | Rowett Res Inst | Bacterial supplement |
DK3067057T3 (da) * | 2005-09-28 | 2023-02-13 | Nordic Rebalance As | Probiotisk fermenteret cerealiesammensætninger til anvendelse ved behandling af gastrointestinale lidelser forårsaget af pro-inflammatoriske bakterier |
CN101353633B (zh) * | 2008-06-13 | 2011-12-28 | 浙江工商大学 | Lactobacillus plantarum ZJ316、产生的抗菌肽及其制备与应用 |
GB0903016D0 (en) * | 2009-02-23 | 2009-04-08 | Univ Gent | Method for alleviating intestinal problems and novel bacterial strains therefor |
DK2498626T3 (en) * | 2009-11-12 | 2015-07-13 | Nestec Sa | FOOD COMPOSITION TO PROMOTE GAS MICROFLORAL BALANCE AND HEALTH |
US8445226B2 (en) * | 2010-02-01 | 2013-05-21 | Microbios, Inc. | Process and composition for the manufacture of a microbial-based product |
US20120034198A1 (en) * | 2010-08-04 | 2012-02-09 | Microbios, Inc. | Carriers for storage and delivery of biologics |
WO2012142605A1 (en) * | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
EP2744890A4 (en) | 2011-09-14 | 2015-07-08 | Univ Kingston | METHOD FOR TREATING DISORDERS OF THE GASTROINTESTINAL DEVICE |
GB201117313D0 (en) * | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
CN103082292B (zh) * | 2011-11-02 | 2015-03-04 | 深圳华大基因研究院 | 罗斯氏菌(Roseburia)在治疗和预防肥胖相关疾病中的应用 |
WO2014075745A1 (en) | 2012-11-19 | 2014-05-22 | Université Catholique de Louvain | Use of akkermansia for treating metabolic disorders |
EP2953472A4 (en) | 2012-11-23 | 2017-03-01 | Seres Therapeutics, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
US8906668B2 (en) * | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
CN105451561A (zh) * | 2013-02-04 | 2016-03-30 | 赛里斯治疗公司 | 组合物和方法 |
AU2014226633A1 (en) * | 2013-03-05 | 2015-09-03 | Academisch Ziekenhuis Groningen | Use of Faecali bacterium prausnitzii HTF-F (DSM 26943) to suppress inflammation. |
WO2014145958A2 (en) | 2013-03-15 | 2014-09-18 | Seres Health, Inc. | Network-based microbial compositions and methods |
MX367109B (es) * | 2013-11-25 | 2019-08-05 | Seres Therapeutics Inc | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. |
EP2944696A1 (en) | 2014-05-13 | 2015-11-18 | Evonik Degussa GmbH | Method of producing organic compounds |
CN113730442A (zh) * | 2014-10-31 | 2021-12-03 | 潘德勒姆治疗公司 | 与病症的微生物治疗和诊断有关的方法和组合物 |
ES2824536T3 (es) * | 2016-02-04 | 2021-05-12 | Univ Gent | Uso de comunidades microbianas para la salud humana y animal |
-
2017
- 2017-02-03 ES ES17703726T patent/ES2824536T3/es active Active
- 2017-02-03 AU AU2017216285A patent/AU2017216285B2/en active Active
- 2017-02-03 MX MX2018009539A patent/MX2018009539A/es unknown
- 2017-02-03 WO PCT/EP2017/052422 patent/WO2017134240A1/en active Application Filing
- 2017-02-03 SI SI201731419T patent/SI3639834T1/sl unknown
- 2017-02-03 DK DK19212983.1T patent/DK3639834T3/da active
- 2017-02-03 BR BR112018015097-5A patent/BR112018015097A2/pt active Search and Examination
- 2017-02-03 SI SI201730441T patent/SI3411052T1/sl unknown
- 2017-02-03 EP EP23182773.4A patent/EP4257194A3/en active Pending
- 2017-02-03 PT PT192129831T patent/PT3639834T/pt unknown
- 2017-02-03 RU RU2018131244A patent/RU2758387C2/ru active
- 2017-02-03 US US16/068,470 patent/US11096971B2/en active Active
- 2017-02-03 EP EP17703726.4A patent/EP3411052B8/en active Active
- 2017-02-03 LT LTEP19212983.1T patent/LT3639834T/lt unknown
- 2017-02-03 RS RS20230900A patent/RS64782B1/sr unknown
- 2017-02-03 HU HUE17703726A patent/HUE051114T2/hu unknown
- 2017-02-03 CA CA3011083A patent/CA3011083A1/en active Pending
- 2017-02-03 EP EP19212983.1A patent/EP3639834B1/en active Active
- 2017-02-03 HR HRP20231182TT patent/HRP20231182T1/hr unknown
- 2017-02-03 HU HUE19212983A patent/HUE063584T2/hu unknown
- 2017-02-03 PL PL19212983.1T patent/PL3639834T3/pl unknown
- 2017-02-03 PL PL17703726T patent/PL3411052T3/pl unknown
- 2017-02-03 IL IL293486A patent/IL293486B2/en unknown
- 2017-02-03 RU RU2021130638A patent/RU2021130638A/ru unknown
- 2017-02-03 CN CN201780008210.7A patent/CN108712906B/zh active Active
- 2017-02-03 ES ES19212983T patent/ES2960781T3/es active Active
- 2017-02-03 RS RS20201197A patent/RS60918B1/sr unknown
- 2017-02-03 JP JP2018560246A patent/JP7016112B2/ja active Active
- 2017-02-03 CN CN202310587729.2A patent/CN116570631A/zh active Pending
- 2017-02-03 FI FIEP19212983.1T patent/FI3639834T3/fi active
- 2017-02-03 DK DK17703726.4T patent/DK3411052T3/da active
- 2017-02-03 LT LTEP17703726.4T patent/LT3411052T/lt unknown
- 2017-02-03 KR KR1020187025280A patent/KR20180127972A/ko active Search and Examination
-
2018
- 2018-06-28 IL IL260337A patent/IL260337B/en active IP Right Grant
- 2018-12-18 HK HK18116238.8A patent/HK1257070A1/zh unknown
-
2020
- 2020-10-08 CY CY20201100950T patent/CY1123954T1/el unknown
-
2021
- 2021-05-31 IL IL283594A patent/IL283594B/en unknown
- 2021-07-27 US US17/386,266 patent/US20210353694A1/en active Pending
- 2021-10-15 US US17/502,401 patent/US20220072071A1/en active Pending
- 2021-10-15 US US17/502,445 patent/US11491196B2/en active Active
- 2021-10-15 US US17/502,454 patent/US20220023357A1/en active Pending
-
2022
- 2022-01-14 JP JP2022004062A patent/JP7460979B2/ja active Active
- 2022-10-03 US US17/937,553 patent/US11633440B2/en active Active
- 2022-10-03 US US17/937,554 patent/US11596658B2/en active Active
-
2023
- 2023-10-10 AU AU2023248066A patent/AU2023248066A1/en active Pending
- 2023-12-04 JP JP2023204439A patent/JP2024028833A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018009539A (es) | Uso de comunidades microbianas para la salud humana y animal. | |
MX2019009132A (es) | Composiciones bacterianas sinergicas y sus metodos de produccion y usos. | |
MX2019014045A (es) | Composiciones y metodos. | |
WO2019099682A9 (en) | Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strains | |
MX2021000388A (es) | Suplemento alimenticio. | |
BR112013027609A2 (pt) | bactérias bacillus para uso no tratamento e prevenção de infecção em animais aquáticos | |
WO2016183532A8 (en) | Bacteria engineered to treat a disease or disorder | |
SE1550189A1 (en) | Therapeutic and prophylactic composition produced by microbiota | |
WO2019066599A3 (ko) | 신규 유산균 및 이의 용도 | |
PH12017500708A1 (en) | Probiotic and prebiotic compositions | |
WO2019178487A3 (en) | Compositions and methods for treating disease using klebsiella quasipneumoniae subsp. similipneumoniae | |
NZ706636A (en) | Probiotic and prebiotic compositions | |
WO2018231992A3 (en) | METHODS OF USING LACTOBACILLUS PLANTARUM STRAINS TO PROTECT ANIMALS AGAINST PATHOGENIC BACTERIAL INFECTION | |
MX2020006191A (es) | Bacteriocinas terapeuticas. | |
SG10201906400SA (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
UA118339C2 (uk) | Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти) | |
WO2014127351A3 (en) | Compositions and methods to alter gut microbial fermentation using sulfate-reducing bacteria | |
MX2019015198A (es) | Tratamiento antimicrobiano de las canales de animales y productos alimenticios. | |
PH12019501439A1 (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
MX2013012045A (es) | Péptidos con actividad antimicrobiana, composiciones farmacéuticas para la profilaxis y el tratamiento de animales, composiciones para la profilaxis y el tratamiento de vegetales, usos de esos péptidos y usos del extracto de paenibacillus elgii ourofinensis. | |
FR3073139B1 (fr) | Composition ameliorant le bien-etre des animaux | |
MX2021006682A (es) | Inhibidores de descarboxilasa para el tratamiento de la enfermedad de parkinson. | |
MX2015005733A (es) | Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad. | |
PH12020551922A1 (en) | Selection and use of melatonin supporting bacteria to reduce infantile colic | |
MX2021009443A (es) | Composiciones que contienen bacterias productoras de bacillaeno o preparaciones de las mismas. |